Clinical Research Facility

Southington, Connecticut 06489

We've found

2 trials

at this facility

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

Status: Enrolling, Phase III
Updated: 3/23/2017

from

Southington, CT

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Status: Enrolling, Phase IV
Updated: 11/2/2015

from

Southington, CT

Use our guide to learn which trials are right for you!